VANGUARD GROUP INC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 75 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 5.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$1,753,000
+142.5%
4,437,259
+246.2%
0.00%
Q2 2022$723,000
-42.6%
1,281,673
+13.9%
0.00%
Q1 2022$1,260,000
-51.5%
1,125,195
-36.7%
0.00%
Q4 2021$2,597,000
-38.6%
1,778,809
+26.2%
0.00%
Q3 2021$4,228,000
-35.7%
1,409,379
-0.6%
0.00%
Q2 2021$6,579,000
-30.7%
1,417,933
-10.4%
0.00%
Q1 2021$9,498,000
+15.3%
1,583,032
+0.7%
0.00%
Q4 2020$8,240,000
+48.0%
1,572,487
-2.3%
0.00%
Q3 2020$5,569,000
-55.6%
1,609,693
+11.5%
0.00%
Q2 2020$12,534,000
+91.3%
1,443,995
+27.8%
0.00%
Q1 2020$6,551,000
-9.0%
1,129,601
+13.1%
0.00%
Q4 2019$7,202,000
+18.6%
998,808
+0.4%
0.00%
Q3 2019$6,070,000
-1.3%
995,041
+53.7%
0.00%
Q2 2019$6,149,000
-2.0%
647,197
-16.3%
0.00%
Q1 2019$6,274,000
-46.7%
773,512
+6.9%
0.00%
-100.0%
Q4 2018$11,765,000
+220.0%
723,520
+220.6%
0.00%
Q3 2018$3,677,000
+116.9%
225,708
+100.6%
0.00%
Q2 2018$1,695,000112,5320.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q4 2021
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$7,294,0008.07%
Invus Financial Advisors, LLC 1,094,998$5,081,0001.01%
Founders Fund V Management, LLC 491,751$2,282,0000.78%
Tibra Equities Europe Ltd 80,700$374,0000.12%
GSA CAPITAL PARTNERS LLP 205,882$955,0000.11%
Hall Private Wealth Advisors 18,500$86,0000.06%
20/20 Capital Management, Inc. 42,840$199,0000.05%
OCCUDO QUANTITATIVE STRATEGIES LP 64,789$301,0000.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 759,918$3,526,0000.02%
PDT Partners, LLC 74,178$344,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders